Hepatitis B pp 175-187 | Cite as

Priorities for the Use of Hepatitis B Vaccine

  • Roger H. Bernier
  • Mark A. Kane
  • Neal Nathanson
  • Donald P. Francis


General recommendations for the use of hepatitis B virus (HBV) vaccine in the United States have been formulated by the Public Health Service’s Immunization Practices Advisory Committee (the ACIP) (1). The recommendations are based on information about the safety and efficacy of the vaccine and on epidemiologic data. The purpose of our presentation is to review the epidemiologic background of hepatitis, describe the existing ACIP recommendations and the issues they have raised, and assess the likely impact of the current approach in achieving control of HBV-related disease.


Universal Vaccination Immunization Practice Advisory Committee Indochinese Refugee Illicit Injectable Drug ACIP Recommendation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    MMWR. (1982). 31:317-322; 327-328.Google Scholar
  2. 2.
    Sobeslavsky, O. (1978). HBV as a global problem, in Viral Hepatitis, G. N. Vyas, S. N. Cohen and R. Schroid, eds., Franklin Institute Press, Philadelphia, pp. 347–355.Google Scholar
  3. 3.
    CDC. (June 1982). Hepatitis Surveillance Report #48.Google Scholar
  4. 4.
    Hadler, S. Personal communication, CDC, Atlanta.Google Scholar
  5. 5.
    Department of State, Bureau of Consular Affairs, Statistics on Immigrant Visa Issuances, FY80-81.Google Scholar
  6. 6.
    Department of State, Refugee Program, Indochinese Refugee Program Summary, period ending November 30, 1982.Google Scholar
  7. 7.
    California Morbidity Supplement, #9, March 12, 1982.Google Scholar
  8. 8.
    Schreeder, M. T., Moser, M. R., Bender, T. R., Sheller, M. J., Murphy, B. L., McMahon, B. J., Heyward, W. L., Hall, D. B., Berquist, K. R., and Maynard, J. G. Prevalence of hepatitis B in Alaska Eskimos. Am. J. Epid. (in press).Google Scholar
  9. 9.
    Ginzberg, H. Personal communication, National Institute on Drug Abuse, Washington, D.C.Google Scholar
  10. 10.
    Alter, M. Personal communication, CDC, Atlanta.Google Scholar
  11. 11.
    Darrow, W. Personal communication, CDC, Atlanta.Google Scholar
  12. 12.
    Szmuness, W., Harley, E. J., and Prince, A. M. (1975). Intrafamilial spread of asymptomatic hepatitis B. Am. J. Med. Sci. 270:293–304.PubMedCrossRefGoogle Scholar
  13. 13.
    Bernier, R. H., Sampliner, R., Gerety, R., Tabor, E., Hamilton, F., and Nathanson, N. (1982). Infection in households of chronic carriers of hepatitis B surface antigen. Am. J. Epid. 116:199–211.Google Scholar
  14. 14.
    Dodd, R. Y., Nath, N., Bastiaans, M. D., and Barker, L. F. (1982). Hepatitis-associated markers in the American Red Cross donor population: Ten years experience, in Viral Hepatitis, 1981 International Symposium, W. Szmuness, H. J. Alter and J. E. Maynard, eds., Franklin Institute Press, Philadelphia, pp. 145–155.Google Scholar
  15. 15.
    Maynard, J. E. (1981). Nosocomial viral hepatitis. Am. J. Med. 70:439–444.PubMedCrossRefGoogle Scholar
  16. 16.
    Dienstag, J. L. and Ryan, D. M. (1982). Occupational exposure to hepatitis B virus in hospital personnel: Infection or immunization. Am. J. Epid. 115:26–39.Google Scholar
  17. 17.
    Mather, S. Personal communication, Veterans Administration, Washington, D.C.Google Scholar
  18. 18.
    MMWR. (1982). 31:465-467.Google Scholar
  19. 19.
    Williamson, T. Personal communication, Merck Sharpe & Dohme, West Point, PA.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Roger H. Bernier
    • 1
  • Mark A. Kane
    • 2
  • Neal Nathanson
    • 3
  • Donald P. Francis
    • 2
  1. 1.Epidemiologic Research Section, Surveillance, Investigations and Research Branch, Division of ImmunizationCDCAtlantaUSA
  2. 2.Hepatitis Branch, Center for Infectious DiseasesCDCAtlantaUSA
  3. 3.Department of MicrobiologyUniversity of Pennsylvania School of MedicinePhiladelphiaUSA

Personalised recommendations